We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
2051
Baker Hughes
BKR
$61.1B
$36K ﹤0.01%
1,100
-16,461
-94% -$559K
BLKB icon
2052
Blackbaud
BLKB
$2.08B
$36K ﹤0.01%
355
-1,600
-82% -$165K
FLXS icon
2053
Flexsteel Industries
FLXS
$311M
$36K ﹤0.01%
+902
New +$34.8K
JACK icon
2054
Jack in the Box
JACK
$335M
$36K ﹤0.01%
420
-626
-60% -$54K
KEX icon
2055
Kirby Corp
KEX
$6.93B
$36K ﹤0.01%
439
-15,952
-97% -$1.38M
NRC icon
2056
NRC Health Common Stock
NRC
$450M
$36K ﹤0.01%
+966
New +$33.7K
ORRF icon
2057
Orrstown Financial Services
ORRF
$838M
$36K ﹤0.01%
+1,377
New +$35.5K
OSPN icon
2058
OneSpan
OSPN
$618M
$36K ﹤0.01%
+1,833
New +$33K
RILY icon
2059
BRC Group Holdings
RILY
$289M
$36K ﹤0.01%
1,603
+719
+81% +$14.9K
SLM icon
2060
SLM Corp
SLM
$5.15B
$36K ﹤0.01%
3,116
-31,211
-91% -$361K
TMF icon
2061
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.17B
$36K ﹤0.01%
+187
New +$34.6K
HZN
2062
DELISTED
Horizon Global Corporation
HZN
$36K ﹤0.01%
6,042
-10,794
-64% -$74.5K
ODT
2063
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$36K ﹤0.01%
1,638
-2,375
-59% -$55.3K
CUB
2064
DELISTED
Cubic Corporation
CUB
$36K ﹤0.01%
560
+60
+12% +$4K
CBL
2065
DELISTED
CBL& Associates Properties, Inc.
CBL
$36K ﹤0.01%
6,540
+940
+17% +$4.5K
BCRH
2066
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$36K ﹤0.01%
+3,248
New +$36.4K
SHLM
2067
DELISTED
Schulman (A.) Inc
SHLM
$36K ﹤0.01%
801
-650
-45% -$28.4K
MACK
2068
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$36K ﹤0.01%
9,170
+6,917
+307% +$45.9K
ADTN icon
2069
Adtran
ADTN
$616M
$35K ﹤0.01%
2,345
+1,496
+176% +$22.3K
CHN
2070
DELISTED
China Fund
CHN
$35K ﹤0.01%
1,656
+936
+130% +$20.4K
CYH icon
2071
Community Health Systems
CYH
$423M
$35K ﹤0.01%
10,526
+7,926
+305% +$33.5K
EPC icon
2072
Edgewell Personal Care
EPC
$1.31B
$35K ﹤0.01%
703
-5,475
-89% -$251K
FNB icon
2073
FNB Corp
FNB
$6.75B
$35K ﹤0.01%
2,577
-24,867
-91% -$335K
FTK icon
2074
Flotek Industries
FTK
$1.28B
$35K ﹤0.01%
1,813
+1,713
+1,713% +$42.5K
LPG icon
2075
Dorian LPG
LPG
$1.96B
$35K ﹤0.01%
4,602
-1,146
-20% -$8.85K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.